AbbVie
ABBV
$172.99
Share price
0.76%
Change (1 day)
3.04%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
AbbVie (ABBV) - Net assets
Net assets on the balance sheet as of December 2024 : $3.36 Billion USD
According to AbbVie's latest financial reports the company has $3.36 Billion USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
AbbVie - Net assets on balance sheet (from 2011 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $$3.36 B | -67.64% |
| 2023-12-31 | $$10.39 B | -39.86% |
| 2022-12-31 | $$17.28 B | 11.99% |
| 2021-12-31 | $$15.43 B | 17.86% |
| 2020-12-31 | $$13.09 B | -260.27% |
| 2019-12-31 | $-$8.18 Billion | -3.24% |
| 2018-12-31 | $-$8.45 Billion | -265.71% |
| 2017-12-31 | $$5.09 B | 9.94% |
| 2016-12-31 | $$4.63 B | 17.52% |
| 2015-12-31 | $$3.94 B | 126.46% |
| 2014-12-31 | $$1.74 B | -61.22% |
| 2013-12-31 | $$4.49 B | 33.57% |
| 2012-12-31 | $$3.36 B | -71.82% |
| 2011-12-31 | $$11.93 B | -24.01% |
| 2010-12-31 | $$15.70 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | $88.49 B | 2,530.71% | 🇺🇸 USA |
 | $16.38 B | 387.16% | 🇺🇸 USA |
 | $14.27 B | 324.24% | 🇺🇸 USA |
 | $5.87 B | 74.70% | 🇺🇸 USA |
 | $19.24 B | 472.12% | 🇺🇸 USA |
 | $16.71 B | 396.91% | 🇺🇸 USA |
 | $16.42 B | 388.16% | 🇬🇧 UK |
 | $40.87 B | 1,114.95% | 🇬🇧 UK |
 | $2.58 B | -23.02% | 🇺🇸 USA |